Scandinavian ChemoTech's subsidiary Vetiqure AB receives a first order from Hasvet Medikal AS
Scandinavian ChemoTech's subsidiary Vetiqure AB has today received a first order from the Turkish distributor Hasvet Medikal AS ”Hasvet”. The order value amounts to EUR 11,200.The order follows the exclusive distributor agreement between Vetiqure and Hasvet that was previously communicated. Through the order, Hasvet can begin marketing in Turkey and demonstrate the benefits of vetIQure´sTM Tumour Specific Electroporation (TSE) technology to the many clinics the company covers. According to Hasvet, Hasvet's market share today amounts to 80% of the Turkish veterinary medicine market, which